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ABSTRACT
Background. Temporal lobe atrophy on magnetic resonance imaging (MRI) has been suggested as
a specific diagnostic marker for Alzheimer’s disease (AD). No previous comparison with dementia
with Lewy bodies (DLB) has been reported.
Method. T1-weighted MRI scans were performed on 11 subjects with AD (nine with
NINCDS}ADRDA probable AD and two with neuropathologically proven AD) and nine subjects
with DLB (four with probable DLB diagnosed by clinical criteria and five with neuropathologically
proven DLB). Groups were matched for age, duration of illness and cognitive test score. Two raters,
blind to diagnosis and neuropathological findings, measured the volumes of the frontal lobes,
temporal lobes, hippocampi, parahippocampal gyri, amygdalae, and caudate nuclei using a
computerized volumetric analysis system. Scans were also rated for medial temporal atrophy on a
four-point scale by an experienced rater.
Results. AD subjects had significantly smaller left temporal lobes and parahippocampal gyri than
those with DLB. Medial temporal atrophy was present in 9}11 AD cases (82%) and absent in 6}9
(67%) of DLB cases. Two neuropathologically confirmed cases of DLB had severe medial temporal
atrophy; both had concurrent AD-type pathology in the temporal lobe (Braak stage 4).
Conclusions. This pilot study supports the hypothesis that a greater burden of pathology centres on
the temporal lobes in AD compared with DLB, except in DLB cases with concurrent Alzheimer
pathology. A larger study is needed to confirm these findings and to determine whether MRI has
a role in assisting with the clinical differentiation between DLB and AD.
INTRODUCTION
Generalized cerebral atrophy is well recognized
to occur in dementia (Jacoby & Levy, 1980) and
atrophy of the medial temporal lobe structures,
especially the hippocampus, is particularly
marked in Alzheimer’s disease (AD) (De la
Monte, 1989; O’Brien, 1995; De Leon et al.
1997). It has been suggested that this pattern of
atrophy may be useful in the distinction between
" Address for correspondence: Dr J. T. O’Brien, Institute for the
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Tyne NE4 6BE.
AD and normal ageing (Jack et al. 1992; Jobst
et al. 1997), benign senescent forgetfulness
(Soininen et al. 1994) and late life depression
and other causes of cognitive impairment
(O’Brien et al. 1997). In a study of neuro-
pathologically confirmed cases, Jobst et al.
(1997) found that the width of the medial
temporal lobe as measured by computerized
tomographic (CT) scanning could distinguish
AD from normal controls and those with other
dementias with a sensitivity of 85% and
specificity of 78%. However, the study included
only four subjects with dementia with Lewy
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bodies (DLB), two of whom had atrophy of the
medial temporal lobe. Atrophy of medial tem-
poral lobe structures has also been reported in
some patients with Parkinson’s disease, both
with and without dementia, in vascular dementia
(Laasko et al. 1996) and in diffuse Lewy body
disease (DLB) (Double et al. 1996). As such, the
usefulness of temporal lobe atrophy in dis-
tinguishing AD from DLB remains to be
determined.
Dementia with Lewy bodies has relatively
recently been described as a common cause of
dementia in old age, accounting for up to 20%
of cases (McKeith et al. 1996), with characteristic
neuropathological and clinical features. Intra-
cytoplasmic, neuronal inclusion bodies (Lewy
bodies) are found in the brainstem, subcortical
nuclei, limbic cortex and neocortex, and clinical
features include fluctuating cognitive impair-
ment, visual hallucinations and parkinsonism.
Consensus criteria for the clinical and neuro-
pathological diagnosis of probable and possible
DLB have been published (McKeith et al. 1996).
There have been no previously published
studies of MRI appearances in DLB. Using CT
scanning, Forstl et al. (1993) examined eight
cases of NINCDS}ADRDA (McKhann et al.
1984) probable AD where Lewy body type
pathology was present at post-mortem (desig-
nated as Lewy body variant of Alzheimer’s
disease). They found that these cases had more
marked frontal cerebral atrophy than those with
pure Alzheimer type pathology. In a neuro-
pathological study, Double et al. (1996) reported
frontal lobe atrophy in DLB, though did not
study an AD group for comparison. In contrast,
Mann & Snowden (1995) found no differences in
atrophy of either the frontal or the temporal
lobes in a neuropathological study comparing
AD and DLB.
We compared regional patterns of atrophy on
structural MRI in cases of AD and DLB. Our
hypothesis was that frontal atrophy be sig-
nificantly greater in patients with DLB, while
atrophy of temporal lobe structures would be
more prominent in patients with AD.
METHOD
Subjects
We included 20 subjects with dementia who had
been referred to Newcastle University Depart-
ment of Old Age Psychiatry. All subjects were
clinically diagnosed by an experienced rater
(I.G.M.) using the NINCDS}ADRDA criteria
for AD (McKhann et al. 1984) and the Con-
sensus criteria for DLB (McKeith et al. 1996).
The clinical diagnoses were made using in-
formation from a thorough clinical assessment,
which involved informant history, dementia
blood screen and cognitive testing including
the Mini-Mental State Examination (MMSE)
(Folstein et al. 1975). Post-mortem neuropatho-
logical data subsequently became available for
seven cases. Pathological diagnosis was made in
accordance with CERAD criteria for AD and
consensus guidelines for DLB (McKeith et al.
1996). Final diagnoses were: nine probable, two
definite AD and four probable and five neuro-
pathologically confirmed DLB (3 predominantly
neocortical DLB, 2 predominantly limbic DLB).
Demographic data (including length of history)
was obtained from the casenotes by a rater blind
to the final diagnosis and to the MRI findings.
MRI scanning
Each patient was scanned on a 0.5 Tesla IGE
MV MAX imager. Initially localizers were
obtained in two planes to correct for asymmetry
of position. Sagittal localizers were obtained
using a T1-weighted (TR 620, TE 21) sequence.
Axial images were obtained using a dual echo
(TR 2080, TE 40}80) sequence. Coronal images
were then obtained using an inversion recovery
sequence (TR 2000, TI 600 and TE 25). In each
patient 14 coronal images were obtained per-
pendicular to the long axis of the temporal lobe
and were of 5 mm thickness with 1 mm gap.
These images were displayed with 1–2 magni-
fication on a standard film format. Anatomical
structures to be measured were defined with
reference to a MRI anatomical atlas (Truwit &
Lempert, 1995). In each subject a reference slice
was identified as the image in which the temporal
and frontal lobes become contiguous and in
which the optic chiasm was seen. The areas of
the lateral ventricles and the right and left
caudate were measured on this slice. Right and
left frontal lobes were measured on the three
slices anterior to the reference slice (slices 1, 2
and 3). The right and left amygdalae were
measured on the reference slice and one slice
posteriorly (slices 0 andfi1). Five slices posterior
to the reference slice (slices fi1, fi2, fi3, fi4
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and fi5) were used to measure the right and left
parahippocampal gyri, the most posterior slice
coinciding with the pulvinar of the thalamus;
slices fi2 to fi5 were used to measure the right
and left hippocampi. Slices 3, 2, 1, 0 fi1, fi2,
fi3, fi4 and fi5 were used to measure the right
and left temporal lobes, the intracranial area
and the whole brain area, excluding the medulla
and brainstem. This approach was adopted
because the coronal slices did not extend to the
very anterior surface of frontal lobe in all cases.
However, all cases had at least three slices
anterior to the reference slice allowing a com-
parable segmented frontal lobe volume to be
calculated for every patient.
Anatomical regions were outlined by visual
cursor tracing and image intensity thresh-
holding and volumes calculated using a com-
mercially available, computerized, software
package (SEESCAN, Cambridge, UK). This
was done by two independent raters who were
blind to the clinical diagnosis. Five randomly
selected cases were evaluated on three separate
occasions to measure intra-rater reliability. In
addition, hard copies of the coronal series were
rated for medial temporal atrophy (MTA) on
the right and left using a previously described 5-
point scale (Scheltens et al. 1992), which assesses
MTA on the basis of increasing width of the
choroidal fissure and temporal horn and de-
creasing height of the hippocampal formation (0
flnormal, 4fl severe MTA). Scores for right
and left were summed to give a total score of
MTA for each subject (0–8).
Statistical analysis
Intra-rater reliability was assessed using the
coefficient of variation (standard deviation}
mean). Inter-rater reliability was calculated
using the Pearson’s correlation coefficient (r).
The ventricle to brain ratio (VBR) was calculated
as the ratio of the area of the lateral ventricle to
the whole brain area on the reference slice (slice
0). Anatomical volumes were calculated by
multiplying regional areas by slice thickness and
summing across the relevant slices. Volumes
were normalized to control for head size by
dividing by total intracranial volume and mul-
tiplying by 10$. Groups comparisons were
performed using t tests with the Statistical
Package for the Social Sciences (SPSS; Norus) is,
1990). Because of the small sample size results
were confirmed using non-parametric (Mann–
Whitney) tests, which did not alter any of the
results presented. Correlations between
normalized temporal and frontal lobe volumes
and clinical variables (age, length of history,
MMSE score) were performed using Pearson’s
correlation coefficient.
RESULTS
There were no significant differences between
groups in age, length of history of dementia or
MMSE score at the time of the scan (Table 1).
The VBR was similar in the two groups; the
mean VBR in the DLB group was 0–066 (s.d.fl
0–036), and in the AD group was 0–087 (s.d.fl
0–036), (Pfl 0–21). Intra-rater reliability was very
good with coefficient of variation as follows:
frontal lobes 1–3%, temporal lobes 3–0%, para-
hippocampal gyrus 3–2%, hippocampus 7–5%,
amygdala 6–8% and caudate 8–5%. Inter-rater
reliability as indicated by correlation coefficients
between raters was also good; frontal lobe rfl
0–93, temporal lobe rfl 0–93, parahippocampal
gyrus rfl 0–51, hippocampus rfl 0–89, amygdala
rfl 0–78, and caudate rfl 0–62 (all P! 0–05).
Mean volume differences between raters were
less than 5% for all areas except hippocampus
(9% for left, 10% for right) and caudate (18%
for left, 12–5% for right).
Comparison between the diagnostic groups
(Table 2) showed a significantly smaller left
temporal lobe volume in AD subjects compared
to those with DLB. The mean corrected volume
of left temporal lobe in the AD subjects was
59–21 (s.d.fl 9–36), and in those with DLB was
68–00 (s.d.fl 6–78) (Pfl 0–03). There was also a
difference in the volume of the left parahippo-
campal gyrus, again the AD group showing a
volume reduction compared to DLB. The mean
corrected volume of parahippocampal gyrus in
Table 1. Demographic characteristics of
patients with Alzheimer’s disease (AD) and
dementia with Lewy bodies (DLB)
AD (Nfl 11) DLB (Nfl 9)
Age in years (mean‡s.d.) 78–8‡5–9 74–8‡6–5
Sex (m}f ) 4}7 4}5
MMSE (mean‡s.d.) 18–3‡2–8 19–1‡6–5
Duration of dementia in months
(mean‡s.d.)
38–2‡19–7 42–7‡25–2
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Table 2. Normalized regional brain volumes in
Alzheimer’s disease (AD) and dementia with Lewy
Bodies (DLB)
AD (Nfl 11) DLB (Nfl 9) P
Hippocampus
Right 2–70‡0–87 3–06‡0–92 0–38
Left 2–68‡0–78 3–13‡0–92 0–24
Parahippocampus
Right 4–99‡0–62 5–23‡1–28 0–58
Left 4–70‡0–42 5–36‡0–62 0–02*
Amygdala
Right 3–13‡0–69 3–40‡0–66 0–39
Left 2–80‡0–73 3–38‡0–74 0–09
Caudate
Right 1–43‡0–27 1–37‡0–37 0–71
Left 1–43‡0–29 1–46‡0–39 0–86
Frontal lobe
Right 67–89‡7–23 69–27‡7–00 0–67
Left 66–41‡6–72 67–96‡7–84 0–64
Temporal lobe
Right 65–48‡11–91 71–07‡5–87 0–19
Left 59–21‡9–36 68–00‡6–78 0–03*
Volumes expressed as mean‡standard deviation and calculated as
volume of region divided by intracranial volume and multiplied by
1000). P values refer to independent t tests (2-tailed).
* P! 0–05.
the AD group was 4–70 (s.d.fl 0–42) and in the
DLB group was 5–36 (s.d.fl 0–62), (Pfl 0–02).
No differences were found in the frontal lobe
volumes. A scatter plot of the left temporal lobe
size by diagnosis is shown in Fig. 1.
MTA ratings for the AD subjects were as
follows: 2, 2, 6, 6, 6, 6, 7, 7, 8, 8, 8. For the DLB
subjects they were: 0, 2, 2, 4, 5, 5, 6, 8, 8. Using
a cut-off of six or more to denote severe MTA,
9}11 AD subjects had severe MTA compared
with only 3}9 DLB subjects. This difference just
failed to reach statistical significance (Fisher’s
exact test, 2-tailed, Pfl 0–065). Two of the three
DLB cases with severe MTA have come to post-
mortem (one limbic, one neocortical DLB) and
both had concurrent Alzheimer-type pathology
in the temporal lobes in the form of tangles
(Braak stage 4). Of the three DLB cases who did
not show severe MTA, two had neocortical
DLB and one limbic DLB. Both AD cases that
had post-mortem confirmation had severe MTA
(scores 6 and 8). Examples of scans are shown in
Fig. 2.
Examination of the relationship of the frontal
and temporal lobe sizes with the clinical variables
of age, length of history and cognitive test score
showed a significant positive correlation between
the size of the right temporal lobe and MMSE
L
ef
t t
em
po
ra
l l
ob
e 
vo
lu
m
es
 c
or
re
ct
ed
 f
or
 h
ea
d 
si
ze
80
75
70
65
60
55
50
45
40
35
AD DLB
Fig. 1. Scatter plot of left temporal lobe volumes corrected for
headsize, in Alzheimer’s disease (AD) and dementia with Lewy
bodies (DLB). (Mean and s.e.m. indicated; D, neuropathologically
confirmed cases.)
score in the AD group, (rfl 0–61, Pfl 0–05).
This correlation was not present on the left side,
(rfl 0–36, Pfl 0–23). There was no equivalent
relationship found in the DLB group, (right
temporal lobe and MMSE score, rflfi0–03,
Pfl 0–94; left temporal lobe and MMSE score,
rflfi0–01, Pfl 0–98). No other correlations
were found to be significant.
DISCUSSION
This is the first study to compare MRI appear-
ances in DLB with AD. Our first hypothesis,
that AD subjects would have greater atrophy of
temporal lobe structures than those with DLB,
was supported using both volumetric and visual
assessment. This fits with previous reports that
suggest selective patterns of atrophy in AD (De
la Monte et al. 1989; Jack et al. 1992; O’Brien,
1995; Jobst et al. 1997). The occurrence of
medial temporal lobe atrophy early in the course
of AD is consistent with the observation that
amnesia is a central and early clinical feature of
the disease, because of the known importance of
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(a)
(b)
Fig. 2. Sample coronal MRI scans of medial temporal lobe showing : (a) relative absence of medial temporal atrophy (combined
visual rating 0) in a subject with dementia with Lewy bodies ; and (b) severe MTA (combined visual rating 6) in a patient with
Alzheimer’s disease. Post-mortem confirmation of diagnosis has been obtained in both these cases.
hippocampus and temporal lobe in mnemonic
function in humans. In contrast to AD, cognitive
impairment in DLB has a different profile, with
impairments in visuospatial function and at-
tention as prominent features, while memory
disturbance often appears only later (McKeith
et al. 1996). Differences have been found also in
the neuropathology of the medial temporal lobe
between DLB and AD, showing significantly
lower numbers of neurofibrillary tangles in the
CA}2 and CA}3 hippocampal regions of
patients with DLB (Ince et al. 1991). This,
together with our findings of relative sparing of
temporal lobe structures on MRI, may explain
some of the differences in cognitive profile of the
two dementias. However, it should be noted that
reports of selective medial temporal lobe atrophy
in AD are not consistent and that studies have
shown atrophy in this area in cases of dementia
with Lewy body pathology (Double et al. 1996;
Laasko et al. 1996; Jobst et al. 1997). Our results
may provide an explanation for such discrepant
results as the two DLB cases that had severe
medial temporal atrophy on visual ratings had
concurrent Alzheimer pathology. Although
based on only five cases, it appeared to be the
presence of Alzheimer-type pathology, rather
than limbic versus neocortical Lewy body path-
ology, which is associated with temporal lobe
atrophy in DLB subjects. This requires con-
firmation in a larger series, though if confirmed
MRI may have a role in identifying in vivo DLB
subjects with concurrent Alzheimer pathology.
In support of this, both Huesgen et al. (1993)
and Nagy et al. (1996) found a strong correlation
between temporal lobe volume loss on MRI and
tangle count at post-mortem. It is also interesting
that we found a significant correlation between
MMSE score and temporal lobe volume in the
AD but not the DLB group. This further
supports the view that the initial basis for
cognitive decline in DLB lies outside atrophic
change and Alzheimer-type pathology in the
temporal lobe.
Studies of frontal lobe pathology in DLB are
also inconclusive ; Forstl et al. (1993) found
greater frontal atrophy in DLB, but this was not
supported by Mann & Snowden (1995) who
found no differences post-mortem between AD
and DLB. In addition, Lippa et al. (1994) report
that neuronal counts in the frontal cortex do not
differ in DLB and AD cases coming to autopsy.
We found neither a significant frontal volume
difference nor trend towards a difference, be-
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tween groups. We may have failed to find a
difference because of the differing imaging
modalities and different patient selection.
Subjects included by Forstl et al. had all fulfilled
NINCDS criteria for probable AD during life
but had unsuspected DLB at post-mortem. In
contrast our subjects all fulfilled clinical criteria
for DLB. Another possibility is that we failed to
find a significant difference either because of
insufficient power of the study or because frontal
lobe volume could not be fully assessed as the
imaging protocol did not include the most
anterior part of the frontal lobes in all subjects.
However, major strengths of this study are the
use of two blind raters who demonstrated
excellent intra and inter-rater reliability, the use
of rigorous standardized diagnostic criteria and
the similarity of the groups with respect to the
important variables of age, MMSE score and
length of history.
We anticipate the clinical diagnosis to be
accurate in an estimated 90% of our cases,
based on studies of the sensitivity and specificity
of similar standardized diagnostic criteria used
previously (Boller et al. 1989; McKeith et al.
1994). This is supported by our clinical dia-
gnoses, which were correct in six of the seven
cases for which we had neuropathological data.
One subject was re-allocated to the AD group
from the DLB group after post-mortem. Of
interest, his MRI scan had shown severe MTA
on visual inspection.
Using the optimum cut-off level which
separated groups (Fig. 2), temporal lobe volume
would have correctly identified nine of the 11
AD subjects and six of the nine DLB subjects,
with exactly the same discrimination obtained
using visual ratings of MTA. Clearly, these
figures must be regarded as very preliminary
given the very small numbers studied and the
arbitrary selection of an optimal cut-off for both
volumetric and visual rating data. However,
they raise the possibility that temporal lobe
MRI may be useful in differentiating AD from
DLB. Our finding of differences in temporal
lobe volumes in the absence of differences in
VBR or frontal lobe volumes shows some
specificity for this result. Timing of the scans in
relation to disease severity may be important,
since Jobst et al. (1997) have suggested that
medial temporal lobe atrophy may be an early
feature in AD, yet occur in other dementias later
in the course However, this cannot be the
explanation in this study since groups were
matched for severity of dementia. An in vivo
investigation which may assist with diagnosis
would be a major advance, since the accurate
clinical diagnosis of DLB is important since
suchpatients showamore rapid cognitive decline
and may have serious adverse reactions to
antipsychotics (McKeith et al. 1996). Further
study of the usefulness of MRI in differentiating
between AD and DLB is required, with the
assessment of a larger number of subjects with
larger magnet strength, thinner slice thickness
and autopsy confirmation of diagnosis in more
cases.
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